AAAAAA

   
Results: 1-7 |
Results: 7
PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: NEWMAN EM CARROLL M AKMAN SA CHOW W COLUZZI P HAMASAKI V LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW SHIBATA S SOMLO G TETEF M YEN Y AHN CW DOROSHOW JH
Citation: Em. Newman et al., PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 254-258
EFFECT OF LOW-DOSE PROPHYLACTIC DOPAMINE ON HIGH-DOSE CISPLATIN-INDUCED ELECTROLYTE WASTING, OTOTOXICITY, AND EPIDERMAL GROWTH-FACTOR EXCRETION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
Authors: SOMLO G DOROSHOW JH LEVRAN A AHN DC HWANG L RASCHKO JW FORMAN SJ MARGOLIN KA MORGAN RJ LEONG LA HAMASAKI VK CHOW WA MOLINA A AHMAD B AKMAN SA KOJIAN A MENARD P
Citation: G. Somlo et al., EFFECT OF LOW-DOSE PROPHYLACTIC DOPAMINE ON HIGH-DOSE CISPLATIN-INDUCED ELECTROLYTE WASTING, OTOTOXICITY, AND EPIDERMAL GROWTH-FACTOR EXCRETION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL, Journal of clinical oncology, 13(5), 1995, pp. 1231-1237
PHASE-I STUDY OF MITOMYCIN-C AND MENADIONE IN ADVANCED SOLID TUMORS
Authors: MARGOLIN KA AKMAN SA LEONG LA MORGAN RJ SOMLO G RASCHKO JW AHN C DOROSHOW JH
Citation: Ka. Margolin et al., PHASE-I STUDY OF MITOMYCIN-C AND MENADIONE IN ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 293-298
PHASE-I STUDY OF 5-DAY CONTINUOUS-INFUSION FLUORODEOXYURIDINE AND HIGH-DOSE FOLINIC ACID WITH ORAL HYDROXYUREA
Authors: RASCHKO JW AKMAN SA LEONG LA MARGOLIN KA MORGAN RJ NEWMAN E SOMLO G AHN C DOROSHOW JH
Citation: Jw. Raschko et al., PHASE-I STUDY OF 5-DAY CONTINUOUS-INFUSION FLUORODEOXYURIDINE AND HIGH-DOSE FOLINIC ACID WITH ORAL HYDROXYUREA, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 161-164
PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 1ST-LINE OR 2ND-LINE THERAPY FOR ADVANCED BREAST-CANCER
Authors: MARGOLIN KA GREEN S OSBORNE K DOROSHOW JH AKMAN SA LEONG LA MORGAN RJ RASCHKO JW SOMLO G HUTCHINS L UPCHURCH C
Citation: Ka. Margolin et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 1ST-LINE OR 2ND-LINE THERAPY FOR ADVANCED BREAST-CANCER, American journal of clinical oncology, 17(2), 1994, pp. 175-180
HIGH-DOSE DOXORUBICIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH STEM-CELLREINFUSION IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER
Authors: SOMLO G DOROSHOW JH FORMAN SJ LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW AKMAN SA AHN C NAGASAWA S HARRISON J STEIN A SMITH E SNIECINSKI I SCHMIDT GM
Citation: G. Somlo et al., HIGH-DOSE DOXORUBICIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH STEM-CELLREINFUSION IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER, Cancer, 73(6), 1994, pp. 1678-1685
HIGH-DOSE CISPLATIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS STEM-CELL REINFUSION IN PATIENTS WITH RESPONSIVE METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER
Authors: SOMLO G DOROSHOW JH FORMAN SJ LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW AKMAN SA AHN C SNIECINSKI I
Citation: G. Somlo et al., HIGH-DOSE CISPLATIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS STEM-CELL REINFUSION IN PATIENTS WITH RESPONSIVE METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER, Cancer, 73(1), 1994, pp. 125-134
Risultati: 1-7 |